Pranolium
dc.contributor.author | Kopia, Gregory A. | en_US |
dc.contributor.author | Eller, Brian T. | en_US |
dc.contributor.author | Patterson, Eugene | en_US |
dc.contributor.author | Lucchesi, Benedict Robert | en_US |
dc.date.accessioned | 2010-06-01T19:02:14Z | |
dc.date.available | 2010-06-01T19:02:14Z | |
dc.date.issued | 1983-03 | en_US |
dc.identifier.citation | Kopia, Gregory A.; Eller, Brian T.; Patterson, Eugene; Lucchesi, Benedict R. (1983). "Pranolium." Cardiovascular Drug Reviews 1(1): 151-201. <http://hdl.handle.net/2027.42/72226> | en_US |
dc.identifier.issn | 0897-5957 | en_US |
dc.identifier.issn | 1527-3466 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/72226 | |
dc.format.extent | 4465218 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1983 Neva Press, Branford, Connecticut | en_US |
dc.title | Pranolium | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan 48109 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/72226/1/j.1527-3466.1983.tb00447.x.pdf | |
dc.identifier.doi | 10.1111/j.1527-3466.1983.tb00447.x | en_US |
dc.identifier.source | Cardiovascular Drug Reviews | en_US |
dc.identifier.citedreference | Ahlmank, G., Saetre, H., and Korsgren, M. ( 1974 ): Reduction of sudden deaths after myocardial infarction. Lancet, 2 ( 7896 ): 1563. | en_US |
dc.identifier.citedreference | Andersen, M. P., Bechsgaard, P., Frederiksen, J., Hansen, D. A., Jurgensen, H. J., Nielsen, B., Pedersen, F., Pedersen-Bjergaard, O., and Rasmussen, S. L. ( 1979 ): Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Lancet, 2 ( 8148 ): 865 – 868. | en_US |
dc.identifier.citedreference | Anderson, J. L., Patterson, E., Conlon, M., Pasyk, S., Pitt, B., and Lucchesi, B. R. ( 1980 ): Kinetics of antifibrillatory effects of bretylium: Correlation with myocardial drug concentration. Am. J. Cardiol., 46: 583 – 592. | en_US |
dc.identifier.citedreference | Anderson, J. L., Patterson, E., Wagner, J. G., Stewart, J. R., Behm, H. L., and Lucchesi, B. R. ( 1980 ): Oral and intravenous bretylium disposition. Clin. Pharmacol. Ther., 28: 468 – 478. | en_US |
dc.identifier.citedreference | Ariens, E. J. ( 1967 ): The structure activity relationships of beta-adrenergic drugs and beta-adrenergic blocking drugs. Ann. N.Y. Acad. Sci., 139: 606 – 631. | en_US |
dc.identifier.citedreference | Balcon, R., Jewitt, D. E., Davies, J. P. H., and Oram, S. ( 1967 ): A controlled trial of propranolol in acute myocardial infarction. Am. Heart J., 74: 582 – 584. | en_US |
dc.identifier.citedreference | Barber, J. M., Boyle, D. McC., Chaturvedi, N. C., Singh, N., and Walsh, M. J. ( 1976 ): Practolol in acute myocardial infarction. Ada Medica Scand., 587 ( Suppl.): 213 – 219. | en_US |
dc.identifier.citedreference | Barber, N. S., Evans, D. W., Howitt, G., Thomas, M., Wilson, C., Lewis, J. A., Dawes, P. M., Handler, K., and Tuson, R. ( 1980 ): Multicenter postinfarction trial of propranolol in 49 hospitals in the United Kingdom, Italy and Yugoslavia. Br. Heart J., 44: 96 – 100. | en_US |
dc.identifier.citedreference | Becker, L. C., Fortuin, N. J., and Pitt, B. ( 1971 ): Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle. Circ. Res., 28: 263 – 269. | en_US |
dc.identifier.citedreference | Bigger, J. T., Dresdale, R. J., Heissenbuttel, R. H., Weld, F. M., and Wit, A. L. ( 1977 ): Ventricular arrhythmias in ischemic heart disease: Mechanism, prevalence, significance and management. Prog. Cardiovasc. Dis., 19: 255 – 296. | en_US |
dc.identifier.citedreference | Braunwald, E. ( 1971 ): Control of myocardial oxygen consumption: Physiologic and clinical considerations. Am. J. Cardiol., 27: 416 – 432. | en_US |
dc.identifier.citedreference | Doyle, J. T. ( 1979 ): The risk of sudden death: The general population. Working group on Arteriosclerosis, NIH, Bethesda. | en_US |
dc.identifier.citedreference | Dresel, P. E., and Potter, P. ( 1978 ): The effect of propranolol and dimethylpropranoiol on cardiac conduction. Can. J. Physiol. Pharmacol., 57: 637 – 641. | en_US |
dc.identifier.citedreference | Durrer, D., Van Lier, A. A. W., and Buller, J. ( 1964 ): Epicardial and intramural excitation in chronic myocardial infarction. Am. Heart J., 68 ), 675. | en_US |
dc.identifier.citedreference | Gibson, J. K., Burmeister, J. L., and Lucchesi, B. R. ( 1978 ): Electrophysiologic effects of UM-272 on myocardial ischemia in the canine heart. J. Pharmacol. Exp. Ther., 207: 304 – 310. | en_US |
dc.identifier.citedreference | Gibson, J. K., Korn, N. L., Counsell, R. E., and Lucchesi, B. R. ( 1979 ): Tissue distribution and antiarrhythmic action of N-dimethylpropranolol (UM-272) in the dog. Fed. Proc., 38 ), 697. | en_US |
dc.identifier.citedreference | Gibson, J. K., and Lucchesi, B. R. ( 1980 ): Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in post-infarction canine myocardium. J. Pharmacol. Exp. Ther., 214: 347 – 353. | en_US |
dc.identifier.citedreference | Grant, R. P., and Murray, R. H. ( 1954 ): The QRS complex deformity of myocardial infarction in the human subject. Am. J. Med., 17 ), 587. | en_US |
dc.identifier.citedreference | Gross, G. J., Warltier, D. C., and Hardman, H. F. ( 1978 ): Beneficial actions of N-dimethyl propranolol on myocardial oxygen balance and transmural perfusion gradients distal to a severe coronary artery stenosis in the canine heart. Circulation, 58: 663 – 669. | en_US |
dc.identifier.citedreference | Gross, G. J., and Winbury, M. M. ( 1973 ): Beta adrenergic blockade on intramyocardial distribution of coronary blood flow. J. Pharmacol. Exp. Ther., 187: 451 – 464. | en_US |
dc.identifier.citedreference | Harris, A. S. ( 1950 ): Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation, 1: 1318 – 1327. | en_US |
dc.identifier.citedreference | Hearse, D. J., Garlick, P. B., and Humphrey, S. M. ( 1977 ): Ischemic contracture of the myocardium: Mechanisms and prevention. Am. J. Cardiol., 39: 986 – 993. | en_US |
dc.identifier.citedreference | Hillis, L. D., Askenazi, J., Braunwald, E., Radvany, P., Muller, I. E., Fishbein, M. C., and Maroko, P. R. ( 1976 ): Uses of changes in epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion. Circulation, 54 ), 591. | en_US |
dc.identifier.citedreference | Hoffman, B. F., and Rosen, M. R. ( 1981 ): Cellular mechanisms for cardiac arrhythmias. Circ. Res., 49: 2 – 15. | en_US |
dc.identifier.citedreference | Holman, B. L., de Wanjee, M. K., Idoine, J., Fliegel, C. P., Davis, M. D., Treves, S., and Eldh, P. ( 1973 ): Detection and localization of experimental myocardial infarction. J. Nucl. Med., 14: 595 – 599. | en_US |
dc.identifier.citedreference | Horowitz, L. N., Josephson, M. E., Farshidi, A., Spielman, S. R., Michelson, E. L., and Greenspan, A. M. ( 1978 ): Recurrent sustained ventricular tachycardia. 3. Role of electrophysiologic study in selection of antiarrhythmic regimens. Circulation, 58: 986 – 998. | en_US |
dc.identifier.citedreference | Horowitz, L. N., Josephson, M. E., and Kastor, J. A. ( 1980 ): Intracardiac electrophysiologic studies as a method for the optimization of drug therapy in chronic ventricular arrhythmia. Prog. Cardiovasc. Dis., 23: 81 – 98. | en_US |
dc.identifier.citedreference | Josephson, M. E., Kastor, J. A., and Horowitz, L. N. ( 1980 ): Electrophysiologic management of recurrent ventricular tachycardia in acute and chronic ischemic heart disease. Cardiovasc. Clin., 11: 35 – 55. | en_US |
dc.identifier.citedreference | Kastor, J. A., Horowitz, L. N., Harken, A. H., and Josephson, M. E. ( 1981 ): Clinical electro-physiology of ventricular tachycardia. N. Engl. J. Med., 304: 1004 – 1020. | en_US |
dc.identifier.citedreference | Katz, A. M., and Tada, M. ( 1977 ): The “stone heart” and other challenges to the biochemist. Am. J. Cardiol., 39: 1073 – 1077. | en_US |
dc.identifier.citedreference | Kjekshus, J. K., and Sobel, B. E. ( 1970 ): Depressed myocardial phosphokinase activity following experimental myocardial infarction in the rabbit. Circ. Res., 27 ), 403. | en_US |
dc.identifier.citedreference | Kniffen, F. J. ( 1973 ): The antiarrhythmic activity of quaternary ammonium compounds. Doctoral Dissertation, University of Michigan. | en_US |
dc.identifier.citedreference | Kniffen, F. J., Lomas, T. E., Burmeister, W. E., and Lucchesi, B. R. ( 1975 ): Effects of dimethyl quaternary propranolol (UM-272) on oxygen consumption and ischemic ST-segment changes in the canine heart. J. Pharmacol. Exp. Ther., 194: 234 – 243. | en_US |
dc.identifier.citedreference | Kniffen, F. J., Lomas, T. E., and Lucchesi, B. R. ( 1974 ): Effects of dl-propranolol and dimethyl propranolol (UM-272) on ischemic ST-segment changes in the canine heart. Fed. Proc., 33 ), 389. | en_US |
dc.identifier.citedreference | Kniffen, F. J., Schuster, D. P., and Lucchesi, B. R. ( 1973 ): Antiarrhythmic and electrophysiologic properties of UM-272, dimethyl quaternary propranolol, in the canine heart. J. Pharmacol. Exp. Ther., 187: 260 – 268. | en_US |
dc.identifier.citedreference | Ku, D. D., and Lucchesi, B. R. ( 1978 ): Effects of dimethyl propranolol (UM-272; SC-27761) on myocardial ischemic injury in the canine heart after temporary coronary artery occlusion. Circulation, 57: 541 – 548. | en_US |
dc.identifier.citedreference | Lazzara, R., El-Sherif, N., Hope, R. R., and Scherlag, B. J. ( 1978 ): Ventricular arrhythmias and electrophysiological consequences of myocardial ischemia and infarction. Circ. Res., 72: 740 – 749. | en_US |
dc.identifier.citedreference | Levine, R. R., and Pelikan, E. W. ( 1961 ): The influence of experimental procedures and dose on the intestinal absorption of an onium compound, benzomethamine. J. Pharmacol. Exp. Ther., 131: 319 – 327. | en_US |
dc.identifier.citedreference | Lindstrom, T. D., Murphy, P. J., Smallwood, J. K., Wiest, S. A., and Steinberg, M. I. ( 1982 ): Correlation between the disposition of 14 C-clofilium and its cardiac electrophysiological effects. J. Pharmacol. Exp. Ther., 221: 584 – 589. | en_US |
dc.identifier.citedreference | Lucchesi, B. R., Burmeister, W. E., Lomas, T. E., and Abrams, G. D. ( 1976 ): Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761). J. Pharmacol. Exp. Ther., 199: 310 – 328. | en_US |
dc.identifier.citedreference | Lucchesi, B. R., and Hardman, H. F. ( 1961 ): The influence of dichloroisoproterenol (DCI) and related compounds upon ouabain and acetylstrophanthidin-induced cardiac arrhythmias. J. Pharmacol. Exp. Ther., 132: 372 – 381. | en_US |
dc.identifier.citedreference | Malek, P., Kolc, J., Zastava, V., Zak, F., and Peleska, B. ( 1963 ): Fluorescence of tetracycline analogues fixed in myocardial infarction. Cardiologica (Basel), 42: 303 – 318. | en_US |
dc.identifier.citedreference | Man, R. V., and Dresel, P. E. ( 1977 ): Effect of lidocaine and methyllidocaine on cardiac conduction. J. Pharmacol. Exp. Ther., 201: 184 – 191. | en_US |
dc.identifier.citedreference | Maroko, P. R., and Braunwald, E. ( 1976 ): Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion. Circulation, 53 ( Suppl. I ): 162 – 168. | en_US |
dc.identifier.citedreference | Maroko, P. R., Kjekshus, J. K., Sobel, B. E., Watanabe, T., Covell, J. W., Ross, J., Jr, and Braunwald, E. ( 1971 ): Factors influencing infarct size following experimental coronary artery occlusion. Circulation, 43: 67 – 82. | en_US |
dc.identifier.citedreference | Michelson, E. L., Naito, M., David, D., Dreifus, L. S., and Moore, E. N. ( 1981 ): Antiarrhythmic efficacy and electropharmacology of clofilium in a chronic canine ventricular tachycardia model. Circulation, 64 ), 124. | en_US |
dc.identifier.citedreference | Michelson, E. L., Spear, J. F., and Moore, E. N. ( 1981 ): Effects of procainamide on strength-interval relations in normal and chronically infarcted canine myocardium. Am. J. Cardiol., 47: 1223 – 1232. | en_US |
dc.identifier.citedreference | 48. Multicentre International Study: Improvement in prognosis of myocardial infarction by long term beta-adrenoceptor blockade using practolol. Br. Med. J., 3 ( 5986 ): 735 – 740. | en_US |
dc.identifier.citedreference | 49. Multicentre International Study: Supplementary report: Reduction in mortality after myocardial infarction with long-term beta-adrenergic blockade. Br. Med. J., 2 ( 6084 ): 419 – 421. | en_US |
dc.identifier.citedreference | Myerburg, R. J., Briese, F. W., Conde, C. A., Mallon, S. M., Liberthson, R. R., and Castellanos, A. ( 1979 ): Antiarrhythmic drug therapy in survivors of prehospital cardiac arrest. Comparison of effects on chronic ventricular arrhythmias and recurrent cardiac arrest. Circulation, 59: 855 – 865. | en_US |
dc.identifier.citedreference | Myerburg, R. J., Kessler, K. M., Kiem, L., Pefkaros, K. C., Conde, C. A., Cooper, D., and Castellanos, A. ( 1981 ): Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of reentrant ventricular tachycardia. Circulation, 64: 280 – 290. | en_US |
dc.identifier.citedreference | Myers, G. B., Klein, H. A., and Hiratzka, T. ( 1948 ): Correlation of electrocardiographic and pathologic findings in anteroposterior infarction. Am. Heart. J., 37 ), 205. | en_US |
dc.identifier.citedreference | Namm, D. H., Wang, C. M., El-Sayad, S., Copp, F., and Maxwell, R. A. ( 1975 ): Effects of bretylium on rat cardiac muscle: The electrophysiological effects and its uptake and binding in normal and immunosympathectomized rat hearts. J. Pharmacol. Exp. Ther., 193: 194 – 207. | en_US |
dc.identifier.citedreference | Morris, R. M., Caughey, D. E., and Scott, P. J. ( 1968 ): Trial of propranolol in acute myocardial infarction. Br. Med. J., 2 ( 5602 ): 398 – 400. | en_US |
dc.identifier.citedreference | 55. Norwegian Multicenter Study Group: Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N. Engl. J. Med., 304: 801 – 807. | en_US |
dc.identifier.citedreference | Olson, R. E. ( 1969 ): Metabolic interventions in the treatment of infarcting myocardium. Circulation, 40 ( Suppl. 4 ): 195 – 201. | en_US |
dc.identifier.citedreference | Olson, E. G., Goodyear, A. V. N., Langon, R. A., Cohen, L. S., and Wolfson, S. ( 1976 ): N-Dimethylisopropyl propranolol: Effects on myocardial oxygen demands. Circulation, 53: 501 – 505. | en_US |
dc.identifier.citedreference | Patterson, E., Gibson, J. K., and Lucchesi, B. R. ( 1980 ): Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. Am. J. Cardiol., 46: 792 – 799. | en_US |
dc.identifier.citedreference | Patterson, E., Stetson, P., and Lucchesi, B. R. ( 1980 ): Plasma and myocardial tissue concentrations of UM-272 (N, N-Dimethyl-propranolol) after oral administration in dogs. J. Pharmacol. Exp. Ther., 214: 449 – 453. | en_US |
dc.identifier.citedreference | Patterson, E., Gibson, J. K., and Lucchesi, B. R. ( 1981 ): Electrophysiologic actions of lidocaine in a canine model of chronic myocardial ischemic injury-arrhythmogenic actions of lidocaine. Circulation, 64 ), 123. | en_US |
dc.identifier.citedreference | Patterson, E., Holland, K., Eller, B., and Lucchesi, B. R. ( 1982 ): Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction—A conscious canine model of sudden coronary death. Am. J. Cardiol., 50: 1414 – 1423. | en_US |
dc.identifier.citedreference | Patterson, E., and Lucchesi, B. R. ( 1981 ): Chronic ventricular tachyarrhythmias in the conscious dog: Prevention by UM-272 (dimethylpropranolol). J. Cardiovasc. Pharmacol., 3: 769 – 780. | en_US |
dc.identifier.citedreference | Patterson, E., and Lucchesi, B. R. ( 1981 ): Antifibrillatory properties of nadolol—Lack of correlation between ventricular fibrillation threshold determinations and programmed electrical stimulation. Circulation, 64 ), 124. | en_US |
dc.identifier.citedreference | Peter, T., Hamamoto, H., Jordon, J., Platt, M., and Mandel, W. ( 1980 ): Indications for antiarrhythmic therapy as prophylaxis against sudden death. Cardiovasc. Clin., 11: 249 – 266. | en_US |
dc.identifier.citedreference | Reele, S., Woosley, D., Komhauser, D., Carr, K., and Shand, D. ( 1978 ): Antiarrhythmic efficacy of pranolium in man. Clin. Res., 26: 264A. | en_US |
dc.identifier.citedreference | Romson, J. R., Haack, D. W., and Lucchesi, B. R. ( 1980 ): Electrical induction of coronary artery thrombosis in the ambulatory canine: A model for in vivo evaluation of antithrombotic agents. Thromb. Res., 17: 841 – 853. | en_US |
dc.identifier.citedreference | Rosen, M. R., Miura, D. S., and Danilo, P. ( 1975 ): The effects of dimethyl quaternary propranolol on the electrophysiologic properties of canine cardiac Purkinje fibers. J. Pharmacol. Exp. Ther., 193: 209 – 217. | en_US |
dc.identifier.citedreference | Ruberman, W., Weinblatt, E., Goldberg, J. D., Frank, C. W., Chaudhary, B. S., and Shapiro, S. ( 1981 ): Ventricular premature complexes and sudden death after myocardial infarction. Circulation, 64: 297 – 305. | en_US |
dc.identifier.citedreference | Ryden, L., Berlin, A., and Freiber, L. R. ( 1975 ): Plasma concentrations and urinary excretion of the antiarrhythmic quaternary ammonium compound, QX-572, in man. Eur. J. Clin. Pharmacol., 8: 277 – 282. | en_US |
dc.identifier.citedreference | Ryden, L., Hjalmarson, A., Wasir, H., and WerkÖ, L. ( 1974 ): Effects of long acting antiarrhythmic agent, Astra QK-572, on refractory ventricular tachyarrhythmias. Br. Heart J., 36: 811 – 821. | en_US |
dc.identifier.citedreference | Schuster, D. P., Lucchesi, B. R., Nobel, N. C., Mimnaugh, M. N., Counsell, R. E., and Kniffen, F. J. ( 1973 ): The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol. J. Pharmacol. Exp. Ther., 184: 213 – 227. | en_US |
dc.identifier.citedreference | Schulze, R. A., Strauss, H. W., and Pitt, B. ( 1977 ): Sudden death in the year following myocardial infarction. Am. J. Med., 62: 192 – 199. | en_US |
dc.identifier.citedreference | Shell, W. E., Kjershus, J. K., and Sobel, B. E. ( 1971 ): Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase (CPK) activity. J. Clin. Invest., 50 ), 2614. | en_US |
dc.identifier.citedreference | Snow, P. J. D. ( 1965 ): Effect of propranoloi in myocardial infarction. Lancet, 2: 551 – 553. | en_US |
dc.identifier.citedreference | Sobel, B. E., Roberts, R., and Larson, K. B., ( 1976 ): Estimation of infarct size from serum MB creatine phosphokinase activity: Applications and limitations. Am. J. Cardiol., 37 ), 474. | en_US |
dc.identifier.citedreference | Stephan, S. A. ( 1966 ): Unwanted effects of propranolol. Am. J. Cardiol., 18: 463 – 472. | en_US |
dc.identifier.citedreference | Sybers, H. O., Ashraf, M., Brauthwaite, J. R., and Lok, M. ( 1972 ): Early myocardial infarction. A fluorescent method of detection. Arch. Pathol., 93: 49 – 54. | en_US |
dc.identifier.citedreference | Turaheim, K., and Lauterbach, F. O. ( 1977 ): Absorption and secretion of monoquaternary ammonium compounds by the isolated intestinal mucosa. Biochem. Pharmacol., 26: 99 – 108. | en_US |
dc.identifier.citedreference | Van de Pol, C. J., Farshidi, A., Spielman, S. R., Greenspan, A. M., Horowitz, L. N., and Josephson, M. E. ( 1980 ): Incidence and clinical significance of induced ventricular tachycardia. Am. J. Cardiol., 45: 725 – 731. | en_US |
dc.identifier.citedreference | Vismara, L. A., Amsterdam, E., and Mason, D. T. ( 1975 ): Relation of ventricular arrhythmias in the late hospital phase of acute myocardial infarction to sudden death after hospital discharge. Am. J. Med., 59: 6 – 12. | en_US |
dc.identifier.citedreference | Vogel, V. M., Romson, J. L., Bush, L. R., Shlafer, M., and Lucchesi, B. R. ( 1980 ): Protective effects of dimethylpropranolol (UM-272) during global ischemia of isolated feline hearts. J. Pharmacol. Exp. Ther., 212: 560 – 568. | en_US |
dc.identifier.citedreference | Warltier, D. C., Gross, G. J., and Hardman, H. F. ( 1978 ): Effect of N-dimethyl propranolol on regional myocardial blood flow and oxygen consumption in the canine heart. J. Pharmacol. Exp. Ther., 204: 294 – 302. | en_US |
dc.identifier.citedreference | Wairen, S., Lucchesi, B., and Shlafer, M. ( 1979 ): Effects of N-dimethyl propranolol (UM-272) on isolated cardiac mitochondria and microsomes. Res. Commun. Chem. Pathol. Pharmacol., 25: 227 – 239. | en_US |
dc.identifier.citedreference | Wilcox, R. G., Roland, J. M., Banks, D. C., Hamptom, J. R., and Mitchell, J. R. A. ( 1980 ): Randomized trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br. Med. J., 280 ( 6218 ); 885 – 888. | en_US |
dc.identifier.citedreference | Wilcox, R. G., Rowley, J. M., Hampton, J. R., Mitchell, J. R. A., Roland, J. M., and Banks, D. C. ( 1980 ): Randomized placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet, 2 ( 8198 ): 765 – 769. | en_US |
dc.identifier.citedreference | Wilhelmsson, C., Vedin, J. A., Wilhelmsson, L., Tibblin, G., and Werko, L. ( 1974 ): Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Lancet, 2 ( 7890 ), 1157 – 1159. | en_US |
dc.identifier.citedreference | Wolfson, S., Olson, E. G., Langon, R. A., Goodyear, A. V. N., and Cohen, L. S. ( 1974 ): N-Dimethylisopropyl propranolol (SC-27761), an analogue without beta-blocking or anesthetic actions: Effects on myocardial demands. Circulation, 50 ( Suppl. III ): 37. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.